EMD Serono, GSK Partner to Advance in Trials New Class of Immunotherapy Against Advanced Cancers
News
Merck KGaA and GlaxoSmithKline (GSK) are working together to develop and commercialize the immunotherapy candidate M7824 (bintrafusp alfa) as a potential treatment for multiple, difficult-to-treat types of cancer. M7824 is being ... Read more